ELVUCITABINE structure
|
Common Name | ELVUCITABINE | ||
|---|---|---|---|---|
| CAS Number | 181785-84-2 | Molecular Weight | 227.192 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 394.9±52.0 °C at 760 mmHg | |
| Molecular Formula | C9H10FN3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 192.6±30.7 °C | |
Use of ELVUCITABINEElvucitabine is an L-nucleoside analogue. Elvucitabine is a potent nucleoside reverse transcriptase (RT) inhibitor. Elvucitabine can be used in research of viral infection[1]. |
| Name | Elvucitabine |
|---|---|
| Synonym | More Synonyms |
| Description | Elvucitabine is an L-nucleoside analogue. Elvucitabine is a potent nucleoside reverse transcriptase (RT) inhibitor. Elvucitabine can be used in research of viral infection[1]. |
|---|---|
| Related Catalog |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 394.9±52.0 °C at 760 mmHg |
| Molecular Formula | C9H10FN3O3 |
| Molecular Weight | 227.192 |
| Flash Point | 192.6±30.7 °C |
| Exact Mass | 227.070618 |
| PSA | 90.37000 |
| LogP | -1.06 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.665 |
| InChIKey | HSBKFSPNDWWPSL-VDTYLAMSSA-N |
| SMILES | Nc1nc(=O)n(C2C=CC(CO)O2)cc1F |
| 4-Amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-2(1H)-pyrimidinone |
| 4-amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one |
| ACH-126,443 |
| 2(1H)-Pyrimidinone, 4-amino-1-[(2S,5R)-2,5-dihydro-5-(hydroxymethyl)-2-furanyl]-5-fluoro- |
| ELVUCITABINE |